323 related articles for article (PubMed ID: 15250017)
1. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
Ramphal R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S25-31. PubMed ID: 15250017
[TBL] [Abstract][Full Text] [Related]
2. Microbiological data for patients with febrile neutropenia.
Kanamaru A; Tatsumi Y
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S7-S10. PubMed ID: 15250014
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
Butt T; Afzal RK; Ahmad RN; Salman M; Mahmood A; Anwar M
J Ayub Med Coll Abbottabad; 2004; 16(1):18-22. PubMed ID: 15125174
[TBL] [Abstract][Full Text] [Related]
4. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
Rolston KV
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S246-52. PubMed ID: 15768330
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
[TBL] [Abstract][Full Text] [Related]
6. Management of fever in neutropenic patients with different risks of complications.
Klastersky J
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
[TBL] [Abstract][Full Text] [Related]
7. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial prophylaxis in febrile neutropenia.
Yoshida M; Ohno R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
[TBL] [Abstract][Full Text] [Related]
9. [Changes in the epidemiology of infections in patients with febrile neutropenia].
Karthaus M; Carratala J
Wien Med Wochenschr; 2001; 151(3-4):47-52. PubMed ID: 11789419
[TBL] [Abstract][Full Text] [Related]
10. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
11. Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade.
Kanafani ZA; Dakdouki GK; El-Chammas KI; Eid S; Araj GF; Kanj SS
Int J Infect Dis; 2007 Sep; 11(5):450-3. PubMed ID: 17337226
[TBL] [Abstract][Full Text] [Related]
12. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
13. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for Gram-negative bacterial infections in febrile neutropenia.
Cordonnier C; Herbrecht R; Buzyn A; Leverger G; Leclercq R; Nitenberg G; Bastuji-Garin S;
Haematologica; 2005 Aug; 90(8):1102-9. PubMed ID: 16079110
[TBL] [Abstract][Full Text] [Related]
16. Bacteraemia in neutropenic patients.
O'Connell B; Daly PA; McCann SR; Keane CT
Ir Med J; 1993; 86(6):203-5. PubMed ID: 8106229
[TBL] [Abstract][Full Text] [Related]
17. Bacteraemia in febrile neutropenic cancer patients.
Klastersky J; Ameye L; Maertens J; Georgala A; Muanza F; Aoun M; Ferrant A; Rapoport B; Rolston K; Paesmans M
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S51-9. PubMed ID: 17689933
[TBL] [Abstract][Full Text] [Related]
18. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
19. Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes.
Sood P; Seth T; Kapil A; Sharma V; Dayama A; Sharma S; Kumar S; Singh AK; Mishra P; Mahapatra M
J Indian Med Assoc; 2012 Jul; 110(7):439-44. PubMed ID: 23520666
[TBL] [Abstract][Full Text] [Related]
20. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]